Search for: "therapies"

OntoChem and its partner Anixa Biosciences Inc. have verified that one of their recently discovered drug-like, small molecule compounds is similar in potency to remdesivir, the only approved antiviral drug agains... read more

Korean investors from PAGS and OntoChem sign a termsheet to jointly develop novel anticancer therapies.

OIS and novomol (www.novomol.com) collaborate to jointly develop new Big Data analytics solutions in the field of compound properties. OntoChem IT Solutions is extracting compound properties from its large scale data collections such as patents... read more

OntoChem presents its CytoPep technology at the American Association for Cancer Research Annual Meeting 2015.
Please visit our poster #1745 “NPY1 Receptor specific Peptide-Drug-Conjugates as novel Treatment for Breast Cancer” ... read more